Australija - engleski - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - olanzapine, quantity: 2.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; hyprolose; lactose monohydrate; microcrystalline cellulose; crospovidone; hypromellose; titanium dioxide; polysorbate 80; macrogol 400 - olanzapine tablets are indicated for the treatment of schizophrenia and related psychoses. ,olanzapine tablets alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. ,olanzapine tablets are also indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - olanzapine, quantity: 7.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; crospovidone; magnesium stearate; hypromellose; hyprolose; titanium dioxide; polysorbate 80; macrogol 400 - olanzapine tablets are indicated for the treatment of schizophrenia and related psychoses. ,olanzapine tablets alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. ,olanzapine tablets are also indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - desmopressin acetate, quantity: 0.2 mg (equivalent: desmopressin, qty 178 microgram) - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; povidone; potato starch - minirin tablets are indicated for the treatment of: cranial diabetes insipidus; primary nocturnal enuresis, in patients from 6 years of age with normal ability to concentrate urine, who are refractory to an enuresis alarm, or in whom an enuresis alarm is contraindicated or inappropriate.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sotalol hydrochloride, quantity: 80 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; methylcellulose; dextrates; magnesium stearate; indigo carmine aluminium lake - prevention and treatment of supraventricular and ventricular arrhythmias.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - sotalol hydrochloride, quantity: 80 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; sodium starch glycollate; hyprolose; magnesium stearate; colloidal anhydrous silica - prevention and treatment of supraventricular and ventricular arrhythmias.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sotalol hydrochloride, quantity: 160 mg - tablet, uncoated - excipient ingredients: magnesium stearate; methylcellulose; dextrates; colloidal anhydrous silica; indigo carmine aluminium lake - prevention and treatment of supraventricular and ventricular arrhythmias.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - sotalol hydrochloride, quantity: 160 mg - tablet, uncoated - excipient ingredients: maize starch; lactose monohydrate; hyprolose; sodium starch glycollate; colloidal anhydrous silica; magnesium stearate - prevention and treatment of supraventricular and ventricular arrhythmias.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - sotalol hydrochloride, quantity: 160 mg - tablet, uncoated - excipient ingredients: maize starch; sodium starch glycollate; purified talc; magnesium stearate; calcium hydrogen phosphate; povidone - for the prevention and treatment of supraventricular and ventricular arrhythmias.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sotalol hydrochloride, quantity: 160 mg - tablet, uncoated - excipient ingredients: magnesium stearate; stearic acid; indigo carmine; maize starch; colloidal anhydrous silica; microcrystalline cellulose; lactose - apx-sotalol is indicated for use in the prevention and treatment of supraventricular and ventricular arrhythmias.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sotalol hydrochloride, quantity: 80 mg - tablet, uncoated - excipient ingredients: lactose; microcrystalline cellulose; indigo carmine; maize starch; colloidal anhydrous silica; magnesium stearate; stearic acid - apx-sotalol is indicated for use in the prevention and treatment of supraventricular and ventricular arrhythmias.